New research presented today at ECTRIMS 2024 reveals that initiating monoclonal antibody therapy during childhood, rather than delaying treatment until early adulthood, significantly reduces long-term disability in multiple sclerosis (MS) patients.
Psilocybin Offers Promising Relief for Cluster Headaches | Psychedelic Invest
Cluster headaches are a debilitating type of headache characterized by excruciating pain, often localized to one side of the head or behind one eye. These